These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36620553)

  • 1. Overexpression of HMGB3 and its prognostic value in breast cancer.
    Zhou X; Zhang Q; Liang G; Liang X; Luo B
    Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Pan-Cancer Analysis Reveals Cyclin-Dependent Kinase Inhibitor 2A Gene as a Potential Diagnostic and Prognostic Biomarker in Colon Adenocarcinoma.
    Salem A; Ahmed S; Khalfallah M; Hamadan N; ElShikh W; Alfaki M
    Cureus; 2024 May; 16(5):e60586. PubMed ID: 38894777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
    Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
    World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of
    Lyu L; Wang M; Zheng Y; Tian T; Deng Y; Xu P; Lin S; Yang S; Zhou L; Hao Q; Wu Y; Dai Z; Kang H
    Cancer Manag Res; 2020; 12():12457-12471. PubMed ID: 33299353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis revealing prognostic significance of
    Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis.
    Fan Y; He L; Wang Y; Fu S; Han Y; Fan J; Wen Q
    Front Mol Biosci; 2020; 7():616190. PubMed ID: 33575272
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression, tumor immune infiltration, and prognostic impact of HMGs in gastric cancer.
    Wu Z; Huang Y; Yuan W; Wu X; Shi H; Lu M; Xu A
    Front Oncol; 2022; 12():1056917. PubMed ID: 36568211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
    Huo Q; Li Z; Cheng L; Yang F; Xie N
    Front Oncol; 2020; 10():621. PubMed ID: 32528869
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
    Han X; Long W; Liu Y; Xu J
    Front Surg; 2022; 9():985034. PubMed ID: 36338652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell division cycle proteinising prognostic biomarker of breast cancer.
    Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCUBE3 serves as an independent poor prognostic factor in breast cancer.
    Huo Q; He X; Li Z; Yang F; He S; Shao L; Hu Y; Chen S; Xie N
    Cancer Cell Int; 2021 May; 21(1):268. PubMed ID: 34006286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the prognostic value of glutathione S-transferases Mu family members in breast cancer.
    Gohari N; Abbasi E; Akrami H
    Cell Biol Int; 2024 Sep; 48(9):1313-1325. PubMed ID: 38922769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
    Li X; Gou J; Li H; Yang X
    Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma.
    Yan J; Xie X; Li Q; Liang P; Zhang J; Xu G
    Heliyon; 2023 Feb; 9(2):e13613. PubMed ID: 36852051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
    Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
    PeerJ; 2023; 11():e15654. PubMed ID: 37520246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
    Yu Z; Cheng L; Liu X; Zhang L; Cao H
    Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.